Case Reports in Oncological Medicine

Volume 2013 (2013), Article ID 354873, 6 pages

http://dx.doi.org/10.1155/2013/354873

Case Report

Cortical Anaplastic Ependymoma with Significant Desmoplasia: A Case Report and Literature Review

Alaa Eldin Elsharkawy,1,2 Raid Abuamona,¹ Markus Bergmann,³ Shadi Salem,¹ Evariste Gafumbegete,⁴ and Ernst Röttger¹

¹Neurosurgical Department, Ludmillenstift Hospital, Ludmillenstraße 4-6, 49716 Meppen, Germany

²Neurosurgical Department, University of Kiel, 24105 Kiel, Germany

³Department of Clinical Neuropathology, Bremen, Germany

⁴Pathological Department, Ludmillenstift Hospital, Meppen, Germany

Received 4 October 2013; Accepted 12 November 2013

Academic Editors: J. Itami, P. F. Lenehan, and M. Ryberg

Copyright © 2013 Alaa Eldin Elsharkawy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Ectopic brain anaplastic ependymomas with no connection to the ventricles are rare. We present a rare case of a 25-year-old male who presented with generalized convulsions. Computed tomography (CT), Magnetic Resonance Imaging (MRI), and magnetic resonance spectroscopy (MRS) showed characters of an intra- and extra-axial lesion. Intraoperatively, the lesion was a cortical solid mass that had no connections to the dura or to the ventricle. The histological diagnosis showed an anaplastic ependymoma with WHO grade III with distinctive desmoplasia. A literature review of ectopic anaplastic ependymomas regarding their clinical presentations, management, and prognostic factors was performed. There is a need to establish a clinically based histopathological grading system for anaplastic ependymomas. Ectopic anaplastic ependymomas should be included in the preoperative differential diagnosis.

1. Introduction

Ependymomas are a subtype of glioma that arise from the ependymal cells within the ventricles and the central canal of the spinal cord. These types of tumors account for 1.9% of all primary CNS tumors [1, 2].

Ependymomas arising outside of the ventricles and that do not have any connections to the ventricles specially cortical ependymomas are very rare [3].

Anaplastic ependymomas account for 8.6% to 11.5% of all ependymomas [1, 4]. The optimal histological grading scale for this type of tumor is not yet defined [5]. The postoperative management and prognostic factors are unknown.

We present a rare case of a cortical anaplastic ependymoma that preoperatively was not typical for intra-axial or extra-axial lesion. We reviewed all cases of ectopic anaplastic ependymomas without connections to the ventricles in the literature to gather information regarding their sites, clinical presentations, pathological features, management, and outcomes.

2. Case Report

A right-handed 25-year-old male presented with a generalized convulsion. He reported having focal-like seizures for years without treatment. He reported slight numbness in his left fourth and fifth fingers. No other symptoms or neurological deficits were present.

The initial brain CT revealed a mass in the right central area that appeared to be a meningioma. An MRI 3-Tesla scan of the brain demonstrated a solid, well-demarcated homogeneous mass which may have a dural attachment (Figure 1). An MRS scan showed a 125% increase in choline. N-Acetyl-aspartate and keratin/phospho-keratin were not observed to be present in the tumor. There was no increased resonance in the lipidarea, and there was no alanine peak. The choline monopeak in the tumor corresponds to an extra-axial tumor, and the lack of resonance in the lipid area confirms the diagnosis of an extra-axial tumor and also excludes a metastasis (Figure 1).

Figure 1: Preoperative MRI showing the mass in the right frontal lobe.

2.1. Intervention

A frontoparietal craniotomy was performed with MRI-guided navigational assistance. Grossly, the lesion was a cortical firm, gray, and solid mass with no connection to the dura matter. The gross lesion appearance and separation from the dural matter allowed for clear planes of dissection between the tumor and normal brain tissue. Intraoperatively, the tumor was not found to be connected to the ventricle. A gross total resection of the mass was achieved. Postoperatively, the patient had no deficits. The preoperative light numbness in his left hand improved during the hospital stay. After diagnosis of an anaplastic ependymoma, an MRI of the total neural axis was performed, without evidence of droop metastasis.

2.2. Pathological Examination

On histological examination, the tumor was primarily of high cellularity and had sharp borders with the surrounding CNS tissue, in which piloid gliosis with rosenthal fibers was seen. The tumor cells were diffusely distributed with little fibrillary intercellular substance. The tumor cell nuclei had finely dispersed chromatin with moderate anisonucleosis and some giant nuclei. Mitotic activity was increased, with up to four mitotic figures seen per high-power field, 11/10 hpf. In fields of lower cellular density, perivascular pseudorosettes were seen. Gemistocytic cells and calcifications were distributed throughout the tumor tissue. Focally, the tumor tissue contained many collagenous fibers.

Immunohistochemically, the tumor cells expressed GFAP, S100, and vimentin. An anti-EMA reaction showed dot-like staining of the microlumina. CD34 was only expressed in the endothelial cells. Thirty percent (30%) of the tumor cell nuclei showed a positive anti-Ki67 reaction.

On electron microscopy, some microlumina and remnants of cilia were detected (Figures 2, 3, 4, 5, and 6).

Figure 2: A patternless, highly cellular lesion is seen with increased mitotic activity (H&E, ×200, original magnification).

Figure 3: Sheets of monomorphic cells were interrupted by perivascular pseudorosettes (H&E, ×200, original magnification).

Figure 4: Paranuclear and ring-like structures were seen in the anti-EMA reaction (anti-EMA, ABC, ×200, original magnification).

Figure 5: Tumor cell processes were GFAP-positive and built up perivascular pseudorosettes (anti-GFAP, ABC, ×200, original magnification).

Figure 6: Ki67-index was increased, with up to 30% positive nuclei (anti-Ki67, ABC, ×200, original magnification).

The final diagnosis was an anaplastic ependymoma with WHO grade III and distinctive desmoplasia (Figures 2, 3, 4, 5, and 6).

2.3. Postoperative Follow-Up

Follow-up at 6 months revealed that the patient had well-controlled epileptic seizure activity, and an MRI of the brain showed no evidence of residual tumor or tumor recurrence. Adjuvant local radiotherapy was performed (Figure 7).

Figure 7: Postoperative MRI showing that the tumor has been totally removed.

2.4. A Literature Review of Ectopic Anaplastic Ependymomas with No Connection to the Ventricle

We identified 24 cases of ectopic anaplastic ependymomas with no connections to the ventricle. There were 13 males (54.2%) and 11 females (45.8%), and the ages ranged between 0.3 and 70 years (mean 28.8 years). Of the 24 ectopic anaplastic ependymoma cases, 22 were located supratentorially (91.7%) and 2 were located infratentorially (8.3%). Nineteen cases (79.2%) were intra-axial and 5 (20.8%) were extra-axial ependymomas. The location, clinical presentation, radiological finding, and outcomes are summarized in Table 1.

Table 1: All of the ectopic anaplastic ependymomas with no connection to the ventricles reported before January 2012.

Series
Sex/age
Location
Clinical presentation
Surgery
Postop. treatment
Recurrence
Outcome
Follow-up

Alexiou et al. [21]
F/10
Rt. Frontal
Headache
GTE
NAT
Cortical
No deficits
6

Davis et al. [19]
F/22
Rt. Frontotemporal
Headache
GTE
Radiotherapy
Metastasis to scalp
No deficits
60

Fukui et al. [13]
M/66
Lt. Posterior fossa
Nerve deficit
GTE
Radiotherapy
Extra-axial cerebellar
No deficits
30

Hamano et al. [11]
M/15
Lt. Parieto-occipital
Headache
GTE
Chemotherapy
Parenchymal with cortical extension
No deficits
12

Kojima et al. [26]
F/56
Lt. Temporal
Seizure
STE
Radiotherapy
Pure cortical
No deficits
5

Kutlay et al. [10]
F/11
Lt. Frontoparietal
Seizure
STE
Radiotherapy
cortical
—

Miyazawa et al. [23]
M/33
Lt. Parietal
Headache
STE
Combined
Extra-axial intratumoral hemorrhage
Mild deficits
10

Moritani et al. [6]
F/50
Rt. Temporal
Headache
STE
Combined
Recurrence in 20 m the exact grading is debatable
—

Ng et al. [27]
F/51
Bifrontal
Incidental
GTE
Radiotherapy
Parenchymal with cortical extension
Handicapped
8

Niazi et al. [15]
F/36
Rt. Frontal
Seizure
GTE
Radiotherapy
Parenchymal with cortical extension
No deficits
29

Niazi et al. [15]
F/18
Rt. Frontoparietal
Seizure
GTE
Radiotherapy
Recurrence
Death
14

Ohla et al. [28]
M/29
Lt. Parietal
Seizure
STE
Radiotherapy
Parenchymal with cortical extension
Death

Park et al. [7]
F/17
Rt. Parafalcine, falx
Seizure
GTE
Radiotherapy
Extra-axial meningioma
Mild deficits
2

Romero et al. [9]
M/23
Lt. Frontal
Seizure
GTE
Radiotherapy
Pure cortical
No deficits
60

Singh et al. [14]
M/35
Lt. Parafalcine, falx
Seizure
GTE
Radiotherapy
Extra-axial meningioma
No deficits
12

Takeshima et al. [8]
F/70
Rt. Frontal
Loss of consciousness
GTE
NAT
Extra-axial intratumoral hemorrhage
Bedridden
36

Thakar et al. [12]
M/12
Brainstem
Headache
Biopsy
Combined
Brainstem
Death
1

Van Gompel et al. [20]
M/12
Rt. Parietal
Seizure
GTE
Radiotherapy
Unusual epileptogenic
No deficits
101

Van Gompel et al. [20]
M/25
Rt. Frontal
Seizure
GTE
Radiotherapy
Unusual epileptogenic
No deficits
80

Van Gompel et al. [20]
M/59
Rt. Frontal
Seizure
GTE
Radiotherapy
Unusual epileptogenic
No deficits
47

Vinchon et al. [22]
M/15
Lt._Insular
Headache
STE
Combined
Recurrence in 3 m
Death
14

Vinchon et al. [22]
M/0.3
Rt. Central
Headache
STE
NAT
Recurrence in 5 m
Death
6

Vinchon et al. [22]
F/13.5
Rt. Temporal
Headache
GTE
Radiotherapy
Recurrence in 8 m
Death
11

Vinchon et al. [22]
M/11.3
Rt. Parietal
Seizure
GTE
Radiotherapy
Recurrence in 20 m
No deficits
80

Present-case
M/25
Rt. Frontal
Seizure
GTE
Radiotherapy
Extra-axial Meningioma
No deficits
6

Lt.: left, Rt.: right, M: male, F: female, GTE: gross total excision, STE: Subtotal excision, NAT: no adjuvant therapy, ND: no deficits.

The frontal location was dominant, being reported in 11 cases (45.9%), including 2 frontoparietal, one frontotemporal, and one central. The most often reported clinical presentation was seizure and medically intractable epilepsy. The most often reported radiological appearance was solid with cystic formation. Preoperatively, 2 cases mimicked a meningioma, and one case mimicked a glioblastoma. Of the 24 anaplastic ependymomas, there was one case in which the exact grading is debatable [6]. Surgical excision was the standard in all of the cases, except in the case involving the brainstem, in which only a biopsy was performed. The majority of the cases were treated with radiotherapy following the surgery.

Of the 24 cases, 12 (50%) patients had no postoperative deficits, 2 (4.2%) had mild deficits, one (4.2%) patient was handicapped, and one (4.2%) patient was bedridden. Six patients (27.3%) died during the follow-up period.

3. Discussion

Ectopic brain ependymomas that do not have any connection to the ventricular system have been reported in all regions of the brain [7–13].

Our unique case had isointense signals on T1- and T2-weighted images and homogeneous contrast enhancement with no dural tail sign. The MRS showed characteristics of an extra-axial lesion. Our case reflects the difficulty in differentiating ectopic anaplastic ependymomas from other dural-based extra-axial lesions and other gliomas on the basis of signal characteristics alone. Due to the rarity of ectopic ependymomas, these tumors are generally not included in the differential diagnosis. Several authors reported anaplastic ependymomas that mimicked meningiomas [7, 14].

Despite the malignant designation of anaplastic ependymomas, they tend to be solid and well demarcated with limited infiltration to the edges of the lesion. The diagnosis of an ectopic anaplastic ependymoma is not easy. The diagnosis varies widely depending on the pathologist’s experience with ependymomas [15–17]. It was reported that approximately 15% of anaplastic ependymoma had a prior diagnosis other than ependymoma, and the tumors were subsequently reclassified as ependymoma [18]. The lack of clinicohistopathological concordance highlights the need for establishing criteria for classifying these tumors according to their degree of anaplasticity.

Surgical excision with adjuvant radiotherapy is the primary management of anaplastic ependymomas [10, 19, 20]. Surgical treatment alone [8, 21, 22] and postoperative combined chemotherapy and radiotherapy were also reported [6, 12, 22, 23]. Chemotherapy has shown only limited efficacy [11]. Chemotherapy may be indicated in cases of incomplete surgical resection and in the pediatric group under the age of two [24, 25].

The 5- and 10-year survival rates reported in the literature were 65% und 37%, respectively, with a great disparity among the studies [22, 29–31]. Certain authors have suggested that supratentorial tumors are more biologically aggressive or recur earlier than infratentorial lesions. Long-term survival appears to be similar for the two locations [22].

Site-related outcomes were reported with the worst outcomes for intraparenchymal anaplastic ependymomas [30]. Successful gross total resection appears to be the best prognostic indicator of long-term survival [15, 31–34]. Favorable prognostic factors reported were older age, a higher local radiation dose, and Caucasian race [35]. Decreased overall survival was reported in cases in which the patient’s age was younger than 15 years, subtotal resection was performed, and adjuvant therapy was used [5].

An increased risk of recurrence was reported with a high histological grade, incomplete resection, and a Karnofsky performance status that is less than or equal to 80 [36].

Tumor grade as a prognostic factor was contradictory; certain authors reported that tumor grade was an independent prognostic factor that influences outcome [37], and others reported that outcomes were not affected by histological grade [22].

4. Conclusion

There is a need to establish a clinically based histopathological grading system for anaplastic ependymomas and a need to increase the awareness of these lesions during preoperative studies.

Conflict of Interests

The authors declare that they have no conflict of interests. They report no financial disclosure.

References

C. S. McGuire, K. L. Sainani, and P. G. Fisher, “Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study—clinical article,” Journal of Neurosurgery, vol. 110, no. 4, pp. 725–729, 2009.

C. J. Campen and P. G. Fisher, “Ependymoma: an overview,” in Tumors of the Central Nervous System, M. A. Hayat, Ed., vol. 8, p. 270, Springer, New York, NY, USA, 2012.

F. Roncaroli, A. Consales, A. Fioravanti et al., “Supratentorial cortical ependymoma: report of three cases,” Neurosurgery, vol. 57, no. 1, p. 192, 2005.

D. Rodríguez, M. C. Cheung, N. Housri, A. Quinones-Hinojosa, K. Camphausen, and L. G. Koniaris, “Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973–2005),” Journal of Surgical Research, vol. 156, no. 2, pp. 340–351, 2009.

D. M.-T. Ho, C.-Y. Hsu, T.-T. Wong, and H. Chiang, “A clinicopathologic study of 81 patients with ependymomas and proposal of diagnostic criteria for anaplastic ependymoma,” Journal of Neuro-Oncology, vol. 54, no. 1, pp. 77–85, 2001.

S. Moritani, R. Kushima, M. Bamba et al., “Highly anaplastic extraventricular ependymoma arising in an adult, mimicking metastatic adenocarcinoma with heavy stromal inflammation and emperiporesis,” Pathology International, vol. 53, no. 8, pp. 539–546, 2003.

E. K. Park, Y.-H. Lee, D.-S. Kim, J.-U. Choi, T.-S. Kim, and K.-W. Shim, “17-year-old girl with headache and complex partial seizure,” Brain Pathology, vol. 20, no. 6, pp. 1111–1114, 2010.

H. Takeshima, T. Kawahara, H. Uchida, H. Hirano, Y.-I. Nakazato, and J.-I. Kuratsu, “Brain surface ependymoma with repeated episodes of intratumoral hemorrhage—case report,” Neurologia Medico-Chirurgica, vol. 42, no. 4, pp. 166–169, 2002.

F. R. Romero, M. A. Zanini, L. G. Ducati, R. B. Vital, N. M. de Lima Neto, and R. C. Gabarra, “Purely cortical anaplastic ependymoma,” Case Reports in Oncological Medicine, vol. 2012, Article ID 541431, 4 pages, 2012.

M. Kutlay, A. Cetinkal, S. Kaya, M. N. Demircan, M. Velioglu, and U. Berber, “Pediatric anaplastic parenchymal ependymoma: case report,” Child's Nervous System, vol. 27, no. 3, pp. 501–505, 2011.

E. Hamano, S. Tsutsumi, Y. Nonaka et al., “Huge supratentorial extraventricular anaplastic ependymoma presenting with massive calcification—case report,” Neurologia Medico-Chirurgica, vol. 50, no. 2, pp. 150–153, 2010.

S. Thakar, D. Mohan, S. V. Furtado, N. Ghosal, and A. S. Hegde, “An anaplastic ependymoma presenting as an intrinsic brainstem glioma,” Neurology India, vol. 60, no. 1, pp. 131–132, 2012.

M. B. Fukui, J. P. Hogg, and A. J. Martinez, “Extraaxial ependymoma of the posterior fossa,” American Journal of Neuroradiology, vol. 18, no. 6, pp. 1179–1181, 1997.

V. Singh, M. K. Turel, G. Chacko, V. Joseph, and V. Rajshekhar, “Supratentorial extra-axial anaplastic ependymoma mimicking a meningioma,” Neurology India, vol. 60, no. 1, pp. 111–113, 2012.

T. N. Niazi, E. M. Jensen, and R. L. Jensen, “WHO Grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options,” Journal of Neuro-Oncology, vol. 91, no. 3, pp. 323–328, 2009.

N. K. Foreman, S. Love, and R. Thorne, “Intracranial ependymomas: analysis of prognostic factors in a population-based series,” Pediatric Neurosurgery, vol. 24, no. 3, pp. 119–125, 1996.

D. Schiffer, A. Chio, M. T. Giordana et al., “Histologic prognostic factors in ependymoma,” Child's Nervous System, vol. 7, no. 4, pp. 177–182, 1991.

T. S. Armstrong, E. Vera-Bolanos, B. N. Bekele, K. Aldape, and M. R. Gilbert, “Adult ependymal tumors: prognosis and the M. D. Anderson Cancer Center experience,” Neuro-Oncology, vol. 12, no. 8, pp. 862–870, 2010.

M. J. Davis, F. Hasan, I. Weinreb, M. C. Wallace, and T.-R. Kiehl, “Extraventricular anaplastic ependymoma with metastasis to scalp and neck,” Journal of Neuro-Oncology, vol. 104, no. 2, pp. 599–604, 2011.

J. J. Van Gompel, K. K. Koeller, F. B. Meyer et al., “Cortical ependymoma: an unusual epileptogenic lesion—clinical article,” Journal of Neurosurgery, vol. 114, no. 4, pp. 1187–1194, 2011.

G. A. Alexiou, D. Panagopoulos, M. Moschovi, K. Stefanaki, G. Sfakianos, and N. Prodromou, “Supratentorial extraventricular anaplastic ependymoma in a 10-year-old girl,” Pediatric Neurosurgery, vol. 46, no. 6, pp. 480–481, 2011.

M. Vinchon, G. Soto-Ares, L. Riffaud, M.-M. Ruchoux, and P. Dhellemmes, “Supratentorial ependymoma in children,” Pediatric Neurosurgery, vol. 34, no. 2, pp. 77–87, 2001.

T. Miyazawa, T. Hirose, K. Nakanishi, Y. Uozumi, N. Tsuzuki, and K. Shima, “Supratentorial ectopic cortical ependymoma occurring with intratumoral hemorrhage,” Brain Tumor Pathology, vol. 24, no. 1, pp. 35–40, 2007.

E. T. Valera, H. R. Machado, A. C. Santos et al., “The use of neoadjuvant chemotherapy to achieve complete surgical resection in recurring supratentorial anaplastic ependymoma,” Child's Nervous System, vol. 21, no. 3, pp. 230–233, 2005.

M. N. Needle, J. W. Goldwein, J. Grass et al., “Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood,” Cancer, vol. 80, pp. 341–347, 1997.

A. Kojima, N. Yamaguchi, S. Okui, M. Kamiya, J. Hirato, and Y. Nakazato, “Parenchymal anaplastic ependymoma with intratumoral hemorrhage: a case report,” Brain Tumor Pathology, vol. 20, no. 2, pp. 85–88, 2003.

D. W. Ng, N. K. King, A. S. Foo, Y. Y. Sitoh, H. Y. Lee, and W. H. Ng, “Anaplastic supratentorial cortical ependymoma presenting as a butterfly lesion,” Surgical Neurology International, vol. 3, p. 107, 2012.

V. Ohla, K. Smith, and C. Drees, “Clinical status epilepticus due to anaplastic cortical ependymoma,” Clinical Neurology and Neurosurgery, vol. 114, pp. 710–712, 2012.

R. Saito, T. Kumabe, M. Kanamori, Y. Sonoda, and T. Tominaga, “Dissemination limits the survival of patients with anaplastic ependymoma after extensive surgical resection, meticulous follow up, and intensive treatment for recurrence,” Neurosurgical Review, vol. 33, no. 2, pp. 185–191, 2010.

J. Guyotat, F. Signorelli, S. Desme et al., “Intracranial ependymomas in adult patients: analyses of prognostic factors,” Journal of Neuro-Oncology, vol. 60, no. 3, pp. 255–268, 2002.

L. Palma, P. Celli, A. Mariottini, A. Zalaffi, and G. Schettini, “The importance of surgery in supratentorial ependymomas. Long-term survival in a series of 23 cases,” Child's Nervous System, vol. 16, no. 3, pp. 170–175, 2000.

K. Mermuys, W. Jeuris, P. K. Vanhoenacker, L. Van Hoe, and P. D'Haenens, “Best cases from the AFIP: supratentorial ependymoma,” Radiographics, vol. 25, no. 2, pp. 486–490, 2005.

S. Ward, B. Harding, P. Wilkins et al., “Gain of 1q and loss of 22 are the most common changes detected by comparative genomic hybridisation in paediatric ependymoma,” Genes Chromosomes and Cancer, vol. 32, no. 1, pp. 59–66, 2001.

K. Bunyaratavej, S. Shuangshoti, J. Tanboon, K. Chantra, and S. Khaoroptham, “Supratentorial lobar anaplastic ependymoma resembling cerebral metastasis: a case report,” Journal of the Medical Association of Thailand, vol. 87, no. 7, pp. 829–833, 2004.

J. W. Goldwein, T. A. Glauser, R. J. Packer et al., “Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors,” Cancer, vol. 66, pp. 557–563, 1990.

P. Metellus, M. Barrie, D. Figarella-Branger et al., “Multicentric French study on adult intracranial ependymomas: prognostic factors analysis and therapeutic considerations from a cohort of 152 patients,” Brain, vol. 130, no. 5, pp. 1338–1349, 2007.

R.-I. Ernestus, R. Schröder, H. Stützer, and N. Klug, “Prognostic relevance of localization and grading in intracranial ependymomas of childhood,” Child's Nervous System, vol. 12, no. 9, pp. 522–526, 1996.